(Q47611490)

English

RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference

23 October 2022

RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

primary immunodeficiency disease

0 references

author name string

Richard L Wasserman

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Benjamin N Greener

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

James Mond

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

publication date

16 October 2017

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 December 2017

1 reference

23 October 2022

Expert Review of Clinical Immunology

2 references

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

23 October 2022

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1107-1119

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Practice parameter for the diagnosis and management of primary immunodeficiency

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: review of the current data

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Subclinical infection and dosing in primary immunodeficiencies

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Respiratory syncytial virus infections in infants affected by primary immunodeficiency.

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy.

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Pulmonary manifestations of primary immunodeficiency disorders in children

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Respiratory syncytial virus: current and emerging treatment options

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Respiratory Syncytial Virus Infections in Pediatric Liver Transplant Recipients

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

The cotton rat model of respiratory viral infections

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Diversifying animal models: the use of hispid cotton rats (Sigmodon hispidus) in infectious diseases

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Respiratory syncytial virus--a comprehensive review

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2017.1389647

21 January 2018

Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-dependent replication of respiratory syncytial virus in the cotton rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic Immunoglobulin Selected for High Antibody Titer to RSV also Contains High Antibody Titers to Other Respiratory Viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathogenesis of respiratory syncytial virus infection in cotton rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palivizumab prophylaxis of respiratory syncytial virus disease in 2000–2001: Results from the palivizumab outcomes registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory syncytial virus infection in cyclophosphamide-treated cotton rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/29035131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1080/1744666X.2017.1389647

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29035131%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47611490&oldid=1756844141"